Company:  NOVO NORDISK A S (NVO)
Form Type:  6-K
Filing Date:  2/13/2018 
CIK:  0000353278 
Address:  NOVO ALLE DK 2880 
City, State, Zip:  BAGSVAERD DENMARK,  00000 
Telephone:  (454) 444-8888 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$46.01  
Change: 
0.81 (1.79%)  
Trade Time: 
04:02 PM EST  
Market Cap: 
$88.00B
Trade NVO now with 

© 2018  
Description of Business
Novo Nordisk A/S was formed in 1989 by a merger of two Danish companies, Nordisk Gentofte A/S and Novo Industri A/S. Novo Industri A/S was the continuing company and its name was changed to Novo Nordisk A/S. The business activities of Nordisk Gentofte were established in 1923 by August Krogh, H. C. Hagedorn and A. Kongsted, and the business activities of Novo Industri A/S were established in 1925 by Harald and Thorvald Pedersen. From the beginning, the business of both companies was production and sale of insulin for the treatment of diabetes. In November 2000 Novo Nordisk spun off its industrial enzyme division into a separate business, Novozymes A/S. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (NOVO-B). Its American Depositary Receipts (ADR) are listed on the New York Stock Exchange (NVO).
Register and access this filing in:     
  FORM 6-K
    SIGNATURES